NEW YORK, July 9, 2013 /PRNewswire/ -- The Galien Foundation today announced the formal program of presenters and panels for its Fourth Galien Forum, scheduled for Tuesday, October 22, 2013 at the Alexandria Life Sciences Center in New York City. The Galien Forum, conducted in conjunction with the prestigious Prix Galien Awards, features roundtable debates focusing on critical, global healthcare issues and challenges. This year's program includes a panel of current industry CEOs tackling the impact of the Affordable Care Act on the biopharmaceutical industry: Ken Frazier (Merck), Alex Gorsky (Johnson & Johnson) and Dr. John Lechleiter (Eli Lilly & Company), moderated by P. Roy Vagelos, M.D. (Chairman of Regeneron Pharmaceuticals and retired Chairman and CEO at Merck).
The Keynote Session will be offered by the renowned Bert Vogelstein, M.D., Professor of Oncology and Pathology, Investigator, Howard Hughes Medical Institute; Director, Ludwig Center for Cancer Genetics & Therapeutics at Johns Hopkins School of Medicine. Long recognized as a "giant of science…whose work has been most influential over the past 20 years," according to The Guardian, Dr. Vogelstein explores the genetic causes of cancer.
Joel S. Marcus, Chairman, Alexandria and Neil de Crescenzo, General Manager, Oracle Health Sciences, long-time supporters of the Galien Foundation mission, will welcome participants.
"In this our Fourth Galien Forum, we are again so honored to have attracted biopharmaceutical leaders, researchers, clinicians and health po
|SOURCE Galien Foundation|
Copyright©2012 PR Newswire.
All rights reserved